Medical equipments, pharmaceuticals and personal care products (Македония - Тендер #46540268)

1. Section I
   1. Name and addresses
      Agency for medicines and medical devices
      Skopje
      1000
      Macedonia
      Telephone: +389 25112394
      E-mail: muaz.halili@malmed.gov.mk
      
   2. Joint procurement
      
   3. Communication
      Access to the procurement documents is restricted. Further information can be obtained at
      https://www.enabavki.gov.mk/PublicAccess/Home.aspx#/home
      Additional information can be obtained from the abovementioned addresselectronically via: https://www.enabavki.gov.mk/PublicAccess/Home.aspx#/home
      to the abovementioned address
      
   4. Type of the contracting authority:
      Ministry or any other national or federal authority, including their regional or local subdivisions
      
   5. Main activity:
      Health
      
2. Section II
   1. Scope of the procurement:
      1. Title:
         

         Procurement of second-generation TKI inhibitors for treatment of patients within PHI University Clinic of Hematology - Skopje

         Reference number: 16946/2023
         
      2. Main CPV code:
         33000000
         
      3. Type of contract:
         Supplies
         
      4. Short description:
         

         Procurement of second-generation TKI inhibitors for treatment of patients with chronic myeloid leukemia within PHI University Clinic of Hematology - Skopje

      5. Estimated total value:
         Value excluding VAT: 18 571 428.00 MKD
         
      6. Information about lots:
         all lots
   2. Description
      1. Title:
         

         Procurement of L01ЕA03, Nilotinib 200 mg

         Lot No: 1
         
      2. Additional CPV code(s):
         33000000
         
      3. Place of performance:
         
      4. Description of the procurement:
         

         Procurement of second-generation TKI inhibitors for treatment of patients with chronic myeloid leukemia within PHI University Clinic of Hematology - Skopje

      5. Award criteria:
         
      6. Estimated value:
         
         
      7. Duration of the contract, framework agreement or dynamic purchasing system:
         Duration in months: 12
         This contract is subject to renewal: no
         
      8. Information about the limits on the number of candidates to be invited:
         
      9. Information about variants:
         Variants will be accepted: no
         
      10. Information about options:
          Options: no
      11. Information about electronic catalogues:
          
          
      12. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      13. Additional information:
          
      14. Title:
          

          Procurement of L01EA02,Dasatinib, 16 mg, 20mg

          Lot No: 2
          
      15. Additional CPV code(s):
          33000000
          
      16. Place of performance:
          
      17. Description of the procurement:
          

          Procurement of second-generation TKI inhibitors for treatment of patients with chronic myeloid leukemia within PHI University Clinic of Hematology - Skopje

      18. Award criteria:
          
      19. Estimated value:
          
          
      20. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: no
          
      21. Information about the limits on the number of candidates to be invited:
          
      22. Information about variants:
          Variants will be accepted: no
          
      23. Information about options:
          Options: no
      24. Information about electronic catalogues:
          
          
      25. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      26. Additional information:
          
      27. Title:
          

          Procurement of L01EA02,Dasatinib, 40 mg, 50mg

          Lot No: 3
          
      28. Additional CPV code(s):
          33000000
          
      29. Place of performance:
          
      30. Description of the procurement:
          

          Procurement of second-generation TKI inhibitors for treatment of patients with chronic myeloid leukemia within PHI University Clinic of Hematology - Skopje

      31. Award criteria:
          
      32. Estimated value:
          
          
      33. Duration of the contract, framework agreement or dynamic purchasing system:
          Duration in months: 12
          This contract is subject to renewal: no
          
      34. Information about the limits on the number of candidates to be invited:
          
      35. Information about variants:
          Variants will be accepted: no
          
      36. Information about options:
          Options: no
      37. Information about electronic catalogues:
          
          
      38. Information about European Union funds:
          The procurement is related to a project and/or programme financed by European Union funds: no
      39. Additional information:
          
3. Section III
   1. Conditions for participation:
      1. Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers:
         List and brief description of conditions:

         To prove their capability for performance of professional activity, the economic operators shall submit document:

         - for registered activity as evidence that they have been registered as natural or legal person for the performance of the activity related to the subject of the contract for public procurement or evidence that they belong to appropriate professional association in accordance with the regulations of the country of registration.

         - Confirmation issued from authorized body for compliance of special criteria for performing legal business activity related to the public procurement subject. A decision issued by the Agency for medicines and medical devices of RM, approving whole sale trading with drugs.

      2. Economic and financial standing:
         
      3. Technical and professional ability:
         List and brief description of selection criteria:

         Declare a statement that the conditions for drugs safe keeping, accommodation, transport and managing are fulfilled pursuant to the Guidance for the conditions related to the space, equipment and human resources for awarding approval for whole sale trade with drugs (Off. Gazette of RM No. 151/08);

         Declare a statement for employee with university degree in medicine or pharmacy in charge for pharmacovigilance and detection of problems in the drugs quality or errors in the drug’s series, submitting his/her data: name, surname, profession and contact phone in order to be available at any time;

         Graduated pharmacist licensed to work in the procurement phases (reception, keeping and issuing drugs).

      4. Information about reserved contracts:
         
   2. Conditions related to the contract:
      1. Information about a particular profession:
         
      2. Information about staff responsible for the performance of the contract:
         
4. Section IV
5. Description:
   1. Type of procedure:
      Open procedure
   2. Information about a framework agreement or a dynamic purchasing system:
      
   3. Information about reduction of the number of solutions or tenders during negotiation or dialogue:
      
   4. Information about negotiation:
      
   5. Information about electronic auction:
      An electronic auction has been used
   6. Information about the Government Procurement Agreement (GPA):
      The procurement is covered by the Government Procurement Agreement: no
6. Administrative information:
   1. Previous publication concerning this procedure:
      
   2. Time limit for receipt of tenders or requests to participate:
      Date: 2023-10-25
      Local time: 11:00
      
   3. Estimated date of dispatch of invitations to tender or to participate to selected candidates:
      
   4. Languages in which tenders or requests to participate may be submitted:
      MK
   5. Minimum time frame during which the tenderer must maintain the tender:
      (from the date stated for receipt of tender)
      
   6. Conditions for opening of tenders:
      Date: 2023-10-25
      Local time: 11:00
      Place:

      Agency for medicines and medical devices

      Information about authorised persons and opening procedure:

      Only authorized representatives of tenderers may attend in the procedure of public opening of the tenders by comments in the minutes on tenders opening.

      Authorized representatives of economic operators shall bring at the public opening authorizations signed by the responsible person of the economic operator.

Источник закупки

Импорт - Экспорт по стране Македония